In the mid-1990s, researchers identified the viral helicase–primase enzyme complex as a target for a potential anti-herpes simplex virus (HSV) therapy. Three decades later, the first promising ...
A recent study In Press at the Journal of Cell Biology reports that herpes simplex virus 1 (HSV-1) exploits heterochromatin to successfully exit the nucleus. The heterochromatin markers macroH2A1 and ...
Unveiling a global crisis: groundbreaking research highlights the immense impact of HSV infections on health, urging a shift towards vaccine innovation and prevention measures. Study: Estimated global ...
Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...
Herpes simplex virus (HSV) is a widespread viral infection that affects millions of people globally. It can occur at any age, and many individuals may carry the virus without showing symptoms, ...
At this year’s annual meeting of the American Society of Gene and Cell Therapy (ASGCT), French biotechnology company EG 427 will share recent advances in the development of its recombinant, ...
Dr. Prince will provide an overview of Herpes Simplex Virus (HSV), including the distinctions between HSV-1 and HSV-2, their anatomical sites of infection, and the mechanisms underlying viral ...